Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now

By Yahoo! Finance | Nov 19, 2024 at 06:59 PM EST

The global genomics market is expanding rapidly due to factors like personalized treatment, gene therapy, and rising cancer rates. The pharmaceutical sector dominated in 2023, with North America leading. Gene editing and cell therapies are growing, with Regeneron Pharmaceuticals showing promising growth potential and innovative treatments.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.